Brief: Prelude Therapeutics Inc CFO Laurent Chardonnet Resigns
10/04/2024 22:10
April 10 (Reuters) - Prelude Therapeutics Inc PRLD.O :
* PRELUDE THERAPEUTICS INC - ON APRIL 8, CO AND LAURENT
CHARDONNET AGREED THAT HE WILL NO LONGER SERVE AS CO'S CFO
* PRELUDE THERAPEUTICS INC - APPOINTED BRYANT D. LIM AS
INTERIM
CFO
Source text for Eikon: ID:n0000950170-24-043347
Further company coverage: PRLD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prelude Therapeutics Incorporated
See all newsBrief: Prelude Announces Clinical Trial Collaboration And Supply Agreement With Lilly To Evaluate KAT6A Selective Degrader PRT13722 In Combination With Verzenio® And Inluriyo® In Patients With HR+/HER2- Breast Cancer
U.S. RESEARCH ROUNDUP-Celcuity, Fluence Energy, Salesforce
Prelude Therapeutics Incorporated reports results for the quarter ended June 30 - Earnings Summary
Prelude Therapeutics Q2 revenue beats analyst expectations, net loss narrows
Prelude Therapeutics Incorporated expected to post a loss of 20 cents a share - Earnings Preview